IPAB rejects Monsanto plant patent
15-07-2013
Image: Novartis AG
India’s Supreme Court has rejected pharmaceutical company Novartis’s application to patent an updated version of its leukaemia drug Glivec, agreeing with the Comptroller General that it lacked novelty.
If you have already subscribed please login.
If you have any technical issues please email tech support.
Novartis, Glivec, India, Supreme Court, patent, pharmaceuticals
